Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Healthcare Momentum ETF

61.60
+0.83081.37%
Volume:42.70K
Turnover:2.60M
Market Cap:287.67M
PE:20.15
High:61.83
Open:60.98
Low:60.60
Close:60.77
52wk High:64.10
52wk Low:39.36
Shares:4.67M
Float Shares:4.67M
Volume Ratio:2.68
T/O Rate:0.91%
Dividend:1.53
Dividend Rate:2.48%
EPS(TTM):3.06
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Analysts Are Bullish on Top Healthcare Stocks: Medtronic (MDT), Guardant Health (GH)

TIPRANKS
·
Sep 02

Guardant Health Shield Blood Test Wins Carelon Coverage for Colorectal Cancer Screening

Reuters
·
Sep 01

Tellgen Corporation Secures Six New Medical Device Approvals

Stock News
·
Sep 01

Medical Sector Hitting an Earnings Inflection Point? 512170 Ends Green Amid AI4S Boost for HK CXO Stocks

Deep News
·
Sep 01

Revolution Medicines Signs Long-Term Headquarters Lease Agreement

TIPRANKS
·
Sep 01

Revolution Medicines (RVMD) Could Be 7% Below Fair Value On FDA Approval Of RASONQUE

Simply Wall St.
·
Sep 01

Shandong Oriental Ocean Secures Regulatory Approval for Its Scavenger Receptor-A Assay Kit

Stock News
·
Sep 01

Affordable Housing Stocks Investors Are Watching As Social Spending Moves Center Stage

Simply Wall St.
·
Sep 01

NASD Most Active Issues

Dow Jones
·
Sep 01

Axsome pullback brings attractive entry point, says H.C. Wainwright

TIPRANKS
·
Aug 31

Axsome Therapeutics, - Doses First Patient in Summit Phase 3 Trial of Axs-05 for Smoking Cessation

THOMSON REUTERS
·
Aug 31

Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking Cessation

GlobeNewswire
·
Aug 31

Revolution Medicines, Inc. : Needham Raises Target Price to $275 from $240

THOMSON REUTERS
·
Aug 31

Guangdong Hybribio Biotech's Subsidiary Secures In Vitro Diagnostic Device Registration Certificate

Stock News
·
Aug 31

Does Guardant Health’s (GH) Patent Appeal Reshape Its Competitive Moat More Than Its Royalty Bill?

Simply Wall St.
·
Aug 30

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Spyre Therapeutics (SYRE)

TIPRANKS
·
Aug 29

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Dow Jones
·
Aug 29

Immunovant Director Atul Pande Disposes of 1,500 Common Shares Worth $64,905

Reuters
·
Aug 29

Revolution Medicines Set to Post 'Strong Launch' for Rasonque, UBS Says

MT Newswires Live
·
Aug 29

Roivant Sets Price for New Rare Disease Drug Lisraya at $35,000 a Month

Reuters
·
Aug 28